Current Cancer Therapy Reviews

Editorial from EIC
pp. 1-1(1)
Author: S. Zaenker, Kurt

Editorial [Hot Topic: The Current World Health Organization Classification of the Myeloproliferative and Myelodysplastic/myeloproliferative Neoplasms and Correlation with Pertinent Targeted Therapy (Guest Editor: Cherie H. Dunphy)]
pp. 2-2(1)
Author: H. Dunphy, Cherie

Chronic Myelogenous Leukemia
pp. 3-13(11)
Author: P. Hasserjian, Robert

Myeloproliferative Neoplasms Including Polycythemia Vera, Essential Thrombocythemia, and Primary Myelofibrosis, Chronic Neutrophilic Leukemia, and Myeloproliferative Neoplasm, Unclassifiable
pp. 14-29(16)
Author: P. Hasserjian, Robert

Chronic Eosinophilic Leukemia, Not Otherwise Specified (CEL, NOS)
pp. 30-34(5)
Author: H. Dunphy, Cherie

Mastocytosis
pp. 35-43(9)
Author: I. George, Tracy

Myeloid and Lymphoid Neoplasms with Eosinophilia and Abnormalities of PDGFRA, PDGFRB or FGFR1
pp. 44-51(8)
Author: H. Dunphy, Cherie

Myelodysplastic/Myeloproliferative Neoplasms
pp. 52-65(14)
Author: H. Dunphy, Cherie

Personalized Diabetes and Cancer Medicine: A Rationale for Anti-Diabetic Nutrition (Bitter Melon) in a Supportive Setting
pp. 66-77(12)
Authors: K.S., Zanker; B., Mang; M, Wolters; A., Hahn